Evidence map›Paper›PMID 21567110›Full record

ArticleIntensive care medicine2011

Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates.

Daniele De Luca, Angelo Minucci, Domenico Tripodi, Marco Piastra, Domenico Pietrini, Cecilia Zuppi, Giorgio Conti, Virgilio P Carnielli, Ettore Capoluongo

Abstract read
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Effect of therapeutic hypothermia on surfactant proteins, anti-inflammatory and pro-fibrotic mediators.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  4. Article
  5. Factors associated with SARS-CoV-2 transplacental transmission.American journal of obstetrics and gynecology · 2022
    Article
  6. Review
  7. Article
  8. Recombinant Human Superoxide Dismutase andMolecules (Basel, Switzerland) · 2019
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2014
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Daniele De LucaLaboratory of Clinical Molecular Biology, Institute of Biochemistry, Servizio Analisi 1, University Hospital A. Gemelli, Catholic University of the Sacred Heart, L.go A. Gemelli 8, 00168, Rome, Italy. dm.deluca@fastwebnet.it
Angelo Minucci
Domenico Tripodi
Marco Piastra
Domenico Pietrini
Cecilia Zuppi
Giorgio Conti
Virgilio P Carnielli
Ettore Capoluongo
Università Cattolica del Sacro Cuore · ITAgostino Gemelli University Polyclinic · ITMarche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMeconium aspiration syndrome (MAS) is a life-threatening neonatal lung injury, whose pathophysiology has been mainly studied in animal models. In such models, pancreatic secretory phospholipase A2 (sPLA2-IB) and proinflammatory cytokines present in meconium challenge the lungs, catabolising surfactant and harming the alveoli. Locally produced phospholipases might perpetuate the injury and influence clinical pictures and therapeutic approaches. Our aim is to verify whether pulmonary phospholipase A2 (sPLA2-IIA) is involved in the damage and to determine if phospholipases and their modulators are associated with MAS clinical pictures.

methodsWe studied distinct phospholipases A2 and their modulators in broncho-alveolar lavage (BAL) fluids and in meconium of five MAS neonates and in five control neonates ventilated for extrapulmonary reasons.

resultsMAS patients have higher amounts of pulmonary phospholipase (sPLA2-IIA; P = 0.016) and Clara cell secretory protein (CCSP; P = 0.032). The local production of such proteins by the lung is confirmed by their very low levels in meconium. sPLA2-IIA contributes to the higher total enzyme activity in MAS patients, as compared to controls (P = 0.008). Cytosolic phospholipase was not detected in meconium or alveolar fluid. sPLA2 activity and sPLA2-IIA concentrations are correlated with the TNFα and with the release of CCSP. sPLA2 total activity, sPLA2-IIA and TNFα concentrations in BAL fluids correlate with the oxygenation impairment and haemorrhagic lung oedema.

conclusionsPulmonary sPLA2 is locally produced and contributes to the total sPLA2 activity during MAS. CCSP is also produced in trying to lower the inflammation. Both sPLA2 activity and sPLA2-IIA are significantly correlated with oxygenation impairment and haemorrhagic lung oedema.

Indexed as

BiomarkersBronchoalveolar Lavage FluidCase-Control StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansInfant, NewbornMaleMeconium Aspiration SyndromePhospholipases A2Prospective StudiesStatistics, NonparametricTumor Necrosis Factor-alphaUteroglobinBiomarkersPhospholipases A2Tumor Necrosis Factor-alphaUteroglobin

Identifiers

PMID21567110
OpenAlexW2030922074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.